Cecilia Jones, Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 5,084 shares at $49.03 ($249K) on 2024-09-26, disclosed to the SEC on 2024-09-30.
Scheduled sale ($249k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.03 | 2,542 | $125K | 50.0% |
| 2 | $49.03 | 2,542 | $125K | 50.0% |
| Total | $49.03 avg | 5,084 | $249K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-09-30 | $268K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $119K | — | Filing → |